Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn's Disease.
暂无分享,去创建一个
B. Claggett | F. Allard | B. Abraham | S. Glover | M. Ciorba | B. Shen | M. Osterman | Julia J. Liu | Elisabeth M. Davis | I. Gordon | E. Yee | Freeha Khan | Xueyan Guo